Back to HZNP Stock Lookup

Horizon Therapeutics (HZNP) – Globe Newswire

Apr 30, 2021 10:00 AM Horizon Therapeutics plc Selects AGC Biologics to Further Supply KRYSTEXXA® (pegloticase injection) at AGC’s Copenhagen Facility
Feb 4, 2021 12:58 AM Dassault Systèmes: Horizon Therapeutics plc Expands Medidata Partnership to Further Enhance Clinical Trial Efficiencies and Outcomes
Feb 1, 2021 02:05 PM VIELA ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of VIE and Encourages Investors to Contact the Firm
Jan 23, 2020 04:38 AM Horizon Therapeutics Secures U.S. FDA Approval for Teprotumumab, for the Treatment of Thyroid Eye Disease (TED)
Oct 24, 2019 08:20 AM AVISE® MTX Test from Exagen Supports Horizon Therapeutics plc Clinical Trial to Evaluate Pegloticase with Methotrexate to Enhance Response Rates for People Living with Uncontrolled Gout

Back to HZNP Stock Lookup